Sialolithiasis of submandibular gland
ICD-10 K11.5 · ICD-11 DA04.4.2

Treatment of Sialolithiasis of the Submandibular Gland

Sialolithiasis of the submandibular gland occurs when calcified stones form within the gland or its duct, obstructing salivary flow. First-line management aims to relieve obstruction and restore normal drainage without surgical intervention where possible.

Initial management is non-invasive and conservative, focused on promoting salivary flow and reducing obstruction through physical and dietary measures applied consistently over time.
The protocol begins with non-invasive conservative measures, including physical stimulation of the gland and targeted hydration practices. Drug treatment — combining agents from two distinct pharmacological classes — may be added depending on the clinical presentation, though not all components are indicated in every case. Full regimen, sequencing, and prescribing details available in the structured protocol →

References

DOI: 10.1051/mbcb/2018039

Non-invasive conservative management of salivary stones consists of gland massage after each meal, daily intake of 1.5 L of water and administration of sialogogues.

A drug treatment consisting of the combination of an antispasmodic (increases the diameter of the ostium promoting canal drainage) and an antibiotic (only in case of infection or invasive treatment, amoxicillin or macrolide).

Gland massage and sialogogues in order to stimulate salivary flow.

View source ↗